Investigating the impact of remote patient monitoring of vital signs on communication and the experience of hospital-in-the-home patients, clinicians, and administrators

Silver Chain Group Limited0 个研究点目标入组 30 人开始时间: 2023年1月10日最近更新: 2023年1月16日

试验速览

暂无简介。

•i.Aged between 40 – 60 years, and
•ii.Enrolled in (or about to be enrolled in) Silver Chain's 'hospital in the home' (HITH)/'hospital at the home' (HATH) programs, and
•iii.Possess a sufficient English proficiency to understand the Participant Information and Consent Form (PICF) without requiring a translator.

•i.Do not speak English/requires a translator.
•ii.Possess a significant cognitive impairment or psychological illness (e.g. dementia) that would inhibit participation (as determined by a Silver Chain clinician).
•iii.Are receiving palliative care.
•iv.Are considered to be a 'high severity' patient:
•a.Is immunocompromised
•b.Is unable to manage pain with simple analgesics
•c.Currently has/previously had diabetic foot ulcers
•d.Currently identified as obese
•e.Currently prescribed multiple courses of intravenous antibiotics.
•v.Are considered to be a 'high bleeding risk' patient:
•a.Recent (within the last 4 weeks) major bleed
•b.Recent (within the last 2 weeks) major surgery
•c.Thrombocytopaenia (platelet count < 50 x 109L)
•d.Known liver disease
•e.Concurrent antiplatelet therapy
•f.Risk of septic shock (fever > 38.5°C; Systolic BP < 90mmHg; HR > 100/min).

发起方

Silver Chain Group Limited